生物制剂与JAK抑制剂的对比. 第一部分:癌症风险. 一个叙事审查
相关实验视频
Updated: Jun 26, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
Miguel Mansilla-Polo1,2,3, Daniel Morgado-Carrasco4,5
1Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Dermatology and therapy
|May 19, 2024
概括
生物药物和Janus激酶抑制剂显示皮肤病患者的癌症风险较低. 然而,长期使用某些药物,如抗TNF和JAK抑制剂,可能会增加患有特定疾病的老年患者的风险.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物药物 (BD) 和Janus激酶抑制剂 (JAKi) 已经改变了皮肤病治疗方法.
- 人们对这些疗法的安全性存在担忧,特别是癌症和感染风险.
研究的目的:
- 审查与皮肤病学中使用的生物药物和JAK抑制剂相关的癌症风险.
- 综合当前关于这些先进皮肤治疗方法安全性概况的证据.
主要方法:
- 2010年1月至2024年2月期间发表的相关研究的叙述性综述.
- 评价BD或JAKi治疗患者癌症风险的文章选择.
主要成果:
- 在BD和JAKi患者中,皮肤癌的发病率与一般人群相似.
- 抗瘤坏死因子 (抗TNFs) 药物和JAK抑制剂 (例如,托法西提尼布,口服鲁克索利提尼布) 与较高的非皮肤癌风险有关.
- 风险因素包括年龄,慢性免疫抑制,类风湿性关节炎 (RA) 等并发症和骨髓质疏松综合征.
- 干白素 (IL) - 17和IL - 23抑制剂可能会降低某些癌症风险.
- 患有牛皮和亚托邦性皮肤炎的患者可能具有较低的恶性瘤风险.
结论:
- 在BD或JAKi患者中,癌症发病率通常很低.
- 在老年患者,RA患者或骨髓质疏松综合征患者以及长期使用特定药物 (托法西提尼布,口服鲁克索利提尼布,抗TNFs) 观察到风险增加.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Vaccines
355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355

